FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:1825-1833 December 5, 2002 Number 23 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Perspective by Cain, M. E. Editorial by Falk, R. H. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background There are two approaches to the treatment of atrial fibrillation: one is cardioversion and treatment with antiarrhythmic drugs to maintain sinus rhythm, and the other is the use of rate-controlling drugs, allowing atrial fibrillation to persist. In both approaches, the use of anticoagulant drugs is recommended.

Methods We conducted a randomized, multicenter comparison of these two treatment strategies in patients with atrial fibrillation and a high risk of stroke or death. The primary end point was overall mortality.

Results A total of 4060 patients (mean [±SD] age, 69.7±9.0 years) were enrolled in the study; 70.8 percent had a history of hypertension, and 38.2 percent had coronary artery disease. Of the 3311 patients with echocardiograms, the left atrium was enlarged in 64.7 percent and left ventricular function was depressed in 26.0 percent. There were 356 deaths among the patients assigned to rhythm-control therapy and 310 deaths among those assigned to rate-control therapy (mortality at five years, 23.8 percent and 21.3 percent, respectively; hazard ratio, 1.15 [95 percent confidence interval, 0.99 to 1.34]; P=0.08). More patients in the rhythm-control group than in the rate-control group were hospitalized, and there were more adverse drug effects in the rhythm-control group as well. In both groups, the majority of strokes occurred after warfarin had been stopped or when the international normalized ratio was subtherapeutic.

Conclusions Management of atrial fibrillation with the rhythm-control strategy offers no survival advantage over the rate-control strategy, and there are potential advantages, such as a lower risk of adverse drug effects, with the rate-control strategy. Anticoagulation should be continued in this group of high-risk patients.

Source Information

The AFFIRM writing group (D.G. Wyse, A.L. Waldo, J.P. DiMarco, M.J. Domanski, Y. Rosenberg, E.B. Schron, J.C. Kellen, H.L. Greene, M.C. Mickel, J.E. Dalquist, and S.D. Corley) assumes overall responsibility for the content of the manuscript.

Address reprint requests to the AFFIRM Clinical Trial Center, Axio Research, 2601 4th Ave., Ste. 200, Seattle, WA 98121, or to leong{at}axioresearch.com.

Full Text of this Article

Related Letters:

Atrial Fibrillation — Rate versus Rhythm Control
Kühlkamp V., Seipel L., Healy E. C., Bhaskarabhatla K., Manning W. J., Wyse D. G., Van Gelder I. C., Crijns H. J.G.M.
Extract | Full Text | PDF  
N Engl J Med 2003; 348:1284-1286, Mar 27, 2003. Correspondence

This article has been cited by other articles:

• Lutomsky, B. A., Rostock, T., Koops, A., Steven, D., Mullerleile, K., Servatius, H., Drewitz, I., Ueberschar, D., Plagemann, T., Ventura, R., Meinertz, T., Willems, S. (2008). Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. Europace 10: 593-599 [Abstract] [Full Text]  
• Thomas, L., Hoy, M., Byth, K., Schiller, N. B. (2008). The left atrial function index: a rhythm independent marker of atrial function. Eur J Echocardiogr 9: 356-362 [Abstract] [Full Text]  
• Meiltz, A., Zimmermann, M., Urban, P., Bloch, A., on behalf of the Association of Cardiologists of t, (2008). Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world. Europace 0: eun086v1-7 [Abstract] [Full Text]  
• Hansen, M. L., Gadsboll, N., Gislason, G. H., Abildstrom, S. Z., Schramm, T. K., Folke, F., Friberg, J., Sorensen, R., Rasmussen, S., Poulsen, H. E., Kober, L., Madsen, M., Torp-Pedersen, C. (2008). Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers. Europace 10: 395-402 [Abstract] [Full Text]  
• Tan, E. S., Rienstra, M., Wiesfeld, A. C.P., Schoonderwoerd, B. A., Hobbel, H. H.F., Van Gelder, I. C. (2008). Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation. Europace 10: 412-418 [Abstract] [Full Text]  
• Noheria, A., Kumar, A., Wylie, J. V. Jr, Josephson, M. E. (2008). Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation: A Systematic Review. Arch Intern Med 168: 581-586 [Abstract] [Full Text]  
• Soran, H., Younis, N., Currie, P., Silas, J., Jones, I.R., Gill, G. (2008). Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation. QJM 101: 181-187 [Abstract] [Full Text]  
• Hemels, M. E.W., Ruiter, J. H., Molhoek, G. P., Veeger, N. J.G.M., Wiesfeld, A. C.P., Ranchor, A. V., van Trigt, M., Pilmeyer, A., Van Gelder, I. C., for The Features in AT500TM study; Chances for pat, (2008). Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study. Europace 10: 306-313 [Abstract] [Full Text]  
• Echahidi, N., Pibarot, P., O'Hara, G., Mathieu, P. (2008). Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery. J Am Coll Cardiol 51: 793-801 [Abstract] [Full Text]  
• Weintraub, W. S. (2008). Predicting Thromboembolism and Selecting Patients for Anticoagulant Therapy in Atrial Fibrillation. J Am Coll Cardiol 51: 816-817 [Full Text]  
• Nademanee, K., Schwab, M. C., Kosar, E. M., Karwecki, M., Moran, M. D., Visessook, N., Michael, A. D., Ngarmukos, T. (2008). Clinical Outcomes of Catheter Substrate Ablation for High-Risk Patients With Atrial Fibrillation. J Am Coll Cardiol 51: 843-849 [Abstract] [Full Text]  
• Arriagada, G., Berruezo, A., Mont, L., Tamborero, D., Molina, I., Coll-Vinent, B., Vidal, B., Sitges, M., Berne, P., Brugada, J., on behalf of the GIRAFA (Grup Integrat de Recerca, (2008). Predictors of arrhythmia recurrence in patients with lone atrial fibrillation. Europace 10: 9-14 [Abstract] [Full Text]  
• Voeller, R. K., Schuessler, R. B., Damiano, R. J. Jr. (2008). Surgical Treatment of Atrial Fibrillation. Card Surg Adult 3: 1375-1394 [Full Text]  
• Cosio, F. G., Aliot, E., Botto, G. L., Heidbuchel, H., Geller, C. J., Kirchhof, P., De Haro, J.-C., Frank, R., Villacastin, J. P., Vijgen, J., Crijns, H. (2008). Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode. Europace 10: 21-27 [Abstract] [Full Text]  
• Donal, E., Sallach, J. A., Murray, R. D., Drinko, J. K., Jasper, S. E., Thomas, J. D., Klein, A. L. (2008). Contrast-enhanced tissue Doppler imaging of the left atrial appendage is a new quantitative measure of spontaneous echocardiographic contrast in atrial fibrillation. Eur J Echocardiogr 9: 5-11 [Abstract] [Full Text]  
• Laurent, G., Moe, G., Hu, X., Holub, B., Leong-Poi, H., Trogadis, J., Connelly, K., Courtman, D., Strauss, B. H., Dorian, P. (2008). Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model. Cardiovasc Res 77: 89-97 [Abstract] [Full Text]  
• Marine, J. E. (2007). Catheter Ablation Therapy for Supraventricular Arrhythmias. JAMA 298: 2768-2778 [Abstract] [Full Text]  
• Vassallo, P., Trohman, R. G. (2007). Use of Amiodarone Reply. JAMA 298: 2618-2618 [Full Text]  
• Moreira, W., Timmermans, C., Wellens, H. J.J., Mizusawa, Y., Philippens, S., Perez, D., Rodriguez, L.-M. (2007). Can Common-Type Atrial Flutter Be a Sign of an Arrhythmogenic Substrate in Paroxysmal Atrial Fibrillation?: Clinical and Ablative Consequences in Patients With Coexistent Paroxysmal Atrial Fibrillation/Atrial Flutter. Circulation 116: 2786-2792 [Abstract] [Full Text]  
• Padeletti, L., Pieragnoli, P., Jentzen, V., Schuchert, A. (2007). The comorbidity of atrial fibrillation and heart failure: a challenge for electrical therapies. Eur Heart J Suppl 9: I81-I86 [Abstract] [Full Text]  
• Niwano, S., Fukaya, H., Sasaki, T., Hatakeyama, Y., Fujiki, A., Izumi, T. (2007). Effect of oral L-type calcium channel blocker on repetitive paroxysmal atrial fibrillation: spectral analysis of fibrillation waves in the Holter monitoring. Europace 9: 1209-1215 [Abstract] [Full Text]  
• Hohnloser, S. H., Pajitnev, D., Pogue, J., Healey, J. S., Pfeffer, M. A., Yusuf, S., Connolly, S. J., for the ACTIVE W Investigators, (2007). Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy: An ACTIVE W Substudy. J Am Coll Cardiol 50: 2156-2161 [Abstract] [Full Text]  
• Kirchhof, P., Auricchio, A., Bax, J., Crijns, H., Camm, J., Diener, H.-C., Goette, A., Hindricks, G., Hohnloser, S., Kappenberger, L., Kuck, K.-H., Lip, G. Y.H., Olsson, B., Meinertz, T., Priori, S., Ravens, U., Steinbeck, G., Svernhage, E., Tijssen, J., Vincent, A., Breithardt, G. (2007). Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eur Heart J 28: 2803-2817 [Abstract] [Full Text]  
• Nutescu, E. A. (2007). ASHP Therapeutic Position Statement on Antithrombotic Therapy in Chronic Atrial Fibrillation. Am J Health Syst Pharm 64: 2281-2291 [Full Text]  
• Neuberger, H.-R., Mewis, C., van Veldhuisen, D. J., Schotten, U., van Gelder, I. C., Allessie, M. A., Bohm, M. (2007). Management of atrial fibrillation in patients with heart failure. Eur Heart J 28: 2568-2577 [Abstract] [Full Text]  
• Kirchhof, P., Auricchio, A., Bax, J., Crijns, H., Camm, J., Diener, H.-C., Goette, A., Hindricks, G., Hohnloser, S., Kappenberger, L., Kuck, K.-H., Lip, G. Y.H., Olsson, B., Meinertz, T., Priori, S., Ravens, U., Steinbeck, G., Svernhage, E., Tijssen, J., Vincent, A., Breithardt, G. (2007). Outcome parameters for trials in atrial fibrillation: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 9: 1006-1023 [Abstract] [Full Text]  
• Alegret, J. M., Vinolas, X., Sagrista, J., Hernandez-Madrid, A., Perez, L., Sabate, X., Mont, L., Medina, A., on behalf of the REVERSE Study Investigators, (2007). Predictors of success and effect of biphasic energy on electrical cardioversion in patients with persistent atrial fibrillation. Europace 9: 942-946 [Abstract] [Full Text]  
• Vassallo, P., Trohman, R. G. (2007). Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications. JAMA 298: 1312-1322 [Abstract] [Full Text]  
• Echahidi, N., Mohty, D., Pibarot, P., Despres, J.-P., O'Hara, G., Champagne, J., Philippon, F., Daleau, P., Voisine, P., Mathieu, P. (2007). Obesity and Metabolic Syndrome Are Independent Risk Factors for Atrial Fibrillation After Coronary Artery Bypass Graft Surgery. Circulation 116: I-213-I-219 [Abstract] [Full Text]  
• Singh, B. N., Connolly, S. J., Crijns, H. J.G.M., Roy, D., Kowey, P. R., Capucci, A., Radzik, D., Aliot, E. M., Hohnloser, S. H., the EURIDIS and ADONIS Investigators, (2007). Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter. NEJM 357: 987-999 [Abstract] [Full Text]  
• Ezekowitz, M. D. (2007). Maintaining Sinus Rhythm -- Making Treatment Better Than the Disease. NEJM 357: 1039-1041 [Full Text]  
• Habara, S., Dote, K., Kato, M., Sasaki, S., Goto, K., Takemoto, H., Hasegawa, D., Matsuda, O. (2007). Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 28: 2217-2222 [Abstract] [Full Text]  
• Tardif, J.-C., Talajic, M. (2007). Perindopril and prevention of atrial fibrillation. Eur Heart J Suppl 9: E25-E29 [Abstract] [Full Text]  
• Jais, P., Packer, D. L. (2007). Ablation vs. drug use for atrial fibrillation. Eur Heart J Suppl 9: G26-G34 [Abstract] [Full Text]  
• Shantsila, E., Watson, T., Lip, G. Y. (2007). Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias. Europace 9: iv37-iv44 [Abstract] [Full Text]  
• Fox, K., Borer, J. S., Camm, A. J., Danchin, N., Ferrari, R., Lopez Sendon, J. L., Steg, P. G., Tardif, J.-C., Tavazzi, L., Tendera, M., for the Heart Rate Working Group, (2007). Resting Heart Rate in Cardiovascular Disease. J Am Coll Cardiol 50: 823-830 [Abstract] [Full Text]  
• Tuzcu, E. M., Starling, R. C., Thomas, J. D. (2007). Highlights of the 56th Annual Scientific Session of the American College of Cardiology, March 24-27, 2007. ACC.07 and i2 Summit Highlights: A Conversation With the Experts.. J Am Coll Cardiol 50: C2-31 [Full Text]  
• Essebag, V., Reynolds, M. R., Hadjis, T., Lemery, R., Olshansky, B., Buxton, A. E., Josephson, M. E., Zimetbaum, P. (2007). Sex Differences in the Relationship Between Amiodarone Use and the Need for Permanent Pacing in Patients With Atrial Fibrillation. Arch Intern Med 167: 1648-1653 [Abstract] [Full Text]  
• Lim, K.-T., Davis, M. J.E., Powell, A., Arnolda, L., Moulden, K., Bulsara, M., Weerasooriya, R. (2007). Ablate and pace strategy for atrial fibrillation: long-term outcome of AIRCRAFT trial. Europace 9: 498-505 [Abstract] [Full Text]  
• Jahangir, A., Lee, V., Friedman, P. A., Trusty, J. M., Hodge, D. O., Kopecky, S. L., Packer, D. L., Hammill, S. C., Shen, W.-K., Gersh, B. J. (2007). Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation: A 30-Year Follow-Up Study. Circulation 115: 3050-3056 [Abstract] [Full Text]  
• Rehman, H. u., Kurnik, D., Loebstein, R., Olchovsky, D., Coceani, M., Skolnik, N., Armon, C., Zimetbaum, P. (2007). Amiodarone for Atrial Fibrillation. NEJM 356: 2424-2426 [Full Text]  
• Calkins, H., Brugada, J., Packer, D. L., Cappato, R., Chen, S.-A., Crijns, H. J.G., Damiano, R. J. Jr, Davies, D. W., Haines, D. E., Haissaguerre, M., Iesaka, Y., Jackman, W., Jais, P., Kottkamp, H., Kuck, K. H., Lindsay, B. D., Marchlinski, F. E., McCarthy, P. M., Mont, J. L., Morady, F., Nademanee, K., Natale, A., Pappone, C., Prystowsky, E., Raviele, A., Ruskin, J. N., Shemin, R. J., TASK FORCE MEMBERS, , Calkins, H., Brugada, J., Section Chairs, , Atrial Fibrillation: Definitions, Mechanisms, and, , Chen, S.-A., Indications for Ablation and Patient Selection, , Prystowsky, E. N., Techniques and Endpoints for Atrial Fibrillation, , Kuck, K. H., Technologies and Tools, , Natale, A., Other Technical Aspects, , Haines, D. E., Follow-up Considerations, , Marchlinski, F. E., Outcomes and Efficacy of Catheter Ablation of Atri, , Calkins, H., Complications of Atrial Fibrillation Ablation, , Davies, D. W., Training Requirements and Competencies, , Lindsay, B. D., Surgical Ablation of Atrial Fibrillation, , McCarthy, P. M., Clinical Trial Considerations, , Packer, D. L., Co-Authors, , Cappato, R., Crijns, H. J.G., Damiano, R. J. Jr, Haissaguerre, M., Jackman, W. M., Jais, P., Iesaka, Y., Kottkamp, H., Mont, L., Morady, F., Nademanee, K., Pappone, C., Raviele, A., Ruskin, J. N., Shemin, R. J. (2007). HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and Approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society.. Europace 9: 335-379 [Full Text]  
• Gupta, D., Earley, M. J, Haywood, G. A, Richmond, L., Fitzgerald, M., Kojodjojo, P., Sporton, S. C, Peters, N. S, Broadhurst, P., Schilling, R. J, Coarse AF Investigators, (2007). Can atrial fibrillation with a coarse electrocardiographic appearance be treated with catheter ablation of the tricuspid valve-inferior vena cava isthmus? Results of a multicentre randomised controlled trial. Heart 93: 688-693 [Abstract] [Full Text]  
• Murphy, N. F, Simpson, C. R, Jhund, P. S, Stewart, S., Kirkpatrick, M., Chalmers, J., MacIntyre, K., McMurray, J. J V (2007). A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart 93: 606-612 [Abstract] [Full Text]  
• Rowan, S. B., Bailey, D. N., Bublitz, C. E., Anderson, R. J. (2007). Trends in Anticoagulation for Atrial Fibrillation in the U.S.: An Analysis of the National Ambulatory Medical Care Survey Database. J Am Coll Cardiol 49: 1561-1565 [Abstract] [Full Text]  
• Hammwohner, M., Ittenson, A., Dierkes, J., Bukowska, A., Klein, H. U., Lendeckel, U., Goette, A. (2007). Platelet Expression of CD40/CD40 Ligand and Its Relation to Inflammatory Markers and Adhesion Molecules in Patients with Atrial Fibrillation. Exp. Biol. Med. 232: 581-589 [Abstract] [Full Text]  
• Hemels, M. E.W., Wiesfeld, A. C.P., Van Veldhuisen, D. J., Van den Berg, M. P., Van Gelder, I. C. (2007). Outcome of pharmacological rhythm control for new-onset persistent atrial fibrillation in patients with systolic heart failure: a comparison with patients with normal left ventricular function. Europace 9: 239-245 [Abstract] [Full Text]  
• Rienstra, M., Van Veldhuisen, D. J., Crijns, H. J.G.M., Van Gelder, I. C., for the RACE investigators, (2007). Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study. Eur Heart J 28: 741-751 [Abstract] [Full Text]  
• Tafreshi, M. J., Rowles, J. (2007). A Review of the Investigational Antiarrhythmic Agent Dronedarone. J CARDIOVASC PHARMACOL THER 12: 15-26 [Abstract]  
• Onorati, F., Bilotta, M., Borrello, F., Vatrano, M., di Virgilio, A., Comi, M. C., Perticone, F., Renzulli, A. (2007). Successful radiofrequency ablation determines atrio-ventricular remodelling and improves systo-diastolic function at tissue Doppler-imaging. Eur. J. Cardiothorac. Surg. 31: 414-422 [Abstract] [Full Text]  
• Zimetbaum, P. (2007). Amiodarone for Atrial Fibrillation. NEJM 356: 935-941 [Full Text]  
• Shemin, R. J., Cox, J. L., Gillinov, A. M., Blackstone, E. H., Bridges, C. R. (2007). Guidelines for Reporting Data and Outcomes for the Surgical Treatment of Atrial Fibrillation. Ann. Thorac. Surg. 83: 1225-1230 [Abstract] [Full Text]  
• Bertaglia, E., Stabile, G., Senatore, G., Colella, A., Del Greco, M., Goessinger, H., Lamberti, F., Lowe, M., Mantovan, R., Peters, N., Pratola, C., Raatikainen, P., Turco, P., Verlato, R. (2007). A clinical and health-economic evaluation of pulmonary vein encircling ablation compared with antiarrhythmic drug treatment in patients with persistent atrial fibrillation (Catheter Ablation for the Cure of Atrial Fibrillation-2 study). Europace 9: 182-185 [Abstract] [Full Text]  
• Anderson, M. E. (2007). Multiple downstream proarrhythmic targets for calmodulin kinase II: Moving beyond an ion channel-centric focus. Cardiovasc Res 73: 657-666 [Abstract] [Full Text]  
• Nasr, I. A., Bouzamondo, A., Hulot, J.-S., Dubourg, O., Le Heuzey, J.-Y., Lechat, P. (2007). Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis. Eur Heart J 0: ehl484v1-6 [Abstract] [Full Text]  
• Sherman, D. G. (2007). Stroke Prevention in Atrial Fibrillation: Pharmacological Rate Versus Rhythm Control. Stroke 38: 615-617 [Abstract] [Full Text]  
• Gillinov, A. M. (2007). Advances in Surgical Treatment of Atrial Fibrillation. Stroke 38: 618-623 [Abstract] [Full Text]  
• Camm, A J, Savelieva, I, Lip, G Y H, on behalf of the Guideline Development Group for t, (2007). Rate control in the medical management of atrial fibrillation. Heart 93: 35-38 [Full Text]  
• Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., Stevenson, W. (2006). The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions. Circulation 114: 2871-2891 [Full Text]  
• Pappone, C., Augello, G., Sala, S., Gugliotta, F., Vicedomini, G., Gulletta, S., Paglino, G., Mazzone, P., Sora, N., Greiss, I., Santagostino, A., LiVolsi, L., Pappone, N., Radinovic, A., Manguso, F., Santinelli, V. (2006). A Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation: The APAF Study. J Am Coll Cardiol 48: 2340-2347 [Abstract] [Full Text]  
• Bajpai, A., Rowland, E. (2006). Atrial fibrillation. Contin Educ Anaesth Crit Care Pain 6: 219-224 [Full Text]  
• Wong, J. W.W., Mak, K.-H. (2006). Impact of Maze and Concomitant Mitral Valve Surgery on Clinical Outcomes. Ann. Thorac. Surg. 82: 1938-1947 [Abstract] [Full Text]  
• Bollmann, A., Husser, D., Mainardi, L., Lombardi, F., Langley, P., Murray, A., Rieta, J. J., Millet, J., Olsson, S. B., Stridh, M., Sornmo, L. (2006). Analysis of surface electrocardiograms in atrial fibrillation: techniques, research, and clinical applications.. Europace 8: 911-926 [Abstract] [Full Text]  
• Van Gelder, I. C., Wyse, D. G., Chandler, M. L., Cooper, H. A., Olshansky, B., Hagens, V. E., Crijns, H. J.G.M., the RACE, , AFFIRM Investigators, (2006). Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies. Europace 8: 935-942 [Abstract] [Full Text]  
• Van Gelder, I. C., Hemels, M. E.W. (2006). The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm. Europace 8: 943-949 [Abstract] [Full Text]  
• Lombardo, R. M.R., Reina, C., Abrignani, M. G., Braschi, A., De Castro, S. (2006). Embolic stroke, sinus rhythm and left atrial mechanical function. Eur J Echocardiogr 7: 401-404 [Abstract] [Full Text]  
• Okin, P. M., Wachtell, K., Devereux, R. B., Harris, K. E., Jern, S., Kjeldsen, S. E., Julius, S., Lindholm, L. H., Nieminen, M. S., Edelman, J. M., Hille, D. A., Dahlof, B. (2006). Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.. JAMA 296: 1242-1248 [Abstract] [Full Text]  
• Hemels, M. E.W., Van Noord, T., Crijns, H. J.G.M., Van Veldhuisen, D. J., Veeger, N. J.G.M., Bosker, H. A., Wiesfeld, A. C.P., Van den Berg, M. P., Ranchor, A. V., Van Gelder, I. C. (2006). Verapamil Versus Digoxin and Acute Versus Routine Serial Cardioversion for the Improvement of Rhythm Control for Persistent Atrial Fibrillation. J Am Coll Cardiol 48: 1001-1009 [Abstract] [Full Text]  
• Holmqvist, F., Stridh, M., Waktare, J. E.P., Sornmo, L., Olsson, S. B., Meurling, C. J. (2006). Atrial fibrillatory rate and sinus rhythm maintenance in patients undergoing cardioversion of persistent atrial fibrillation. Eur Heart J 27: 2201-2207 [Abstract] [Full Text]  
• Lombardi, F., Borggrefe, M., Ruzyllo, W., Luderitz, B., for the A-COMET-II Investigators, (2006). Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial. Eur Heart J 27: 2224-2231 [Abstract] [Full Text]  
• Writing Committee Members, , Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8: 651-745 [Full Text]  
• Nergardh, A, Frick, M (2006). Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation. Heart 92: 1244-1247 [Abstract] [Full Text]  
• Betts, T R (2006). Rhythm control strategies for "symptomatic" persistent atrial fibrillation: is achieving sinus rhythm enough?. Heart 92: 1189-1190 [Abstract] [Full Text]